Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and MMF for GVHD Prophylaxis in HCT
NCT00350181Phase 2Completed
- Sponsor
- Stanford University
- Start
- Aug 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus, mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by Stanford University. Started Aug 2006; status: completed.
02
Drugs
sirolimusmycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00350181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350181.